Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

BACKGROUND: Paediatric acute myeloid leukaemia (AML) is characterized by poor outcomes in patients with relapsed/refractory disease, despite the improvements in intensive standard therapy. The leukaemic cells of paediatric AML patients show high expression of the CD123 antigen, and this finding prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Simona, De Angelis, Biagio, Del Bufalo, Francesca, Ciccone, Roselia, Donsante, Samantha, Volpe, Gabriele, Manni, Simona, Guercio, Marika, Pezzella, Michele, Iaffaldano, Laura, Silvestris, Domenico Alessandro, Sinibaldi, Matilde, Di Cecca, Stefano, Pitisci, Angela, Velardi, Enrico, Merli, Pietro, Algeri, Mattia, Lodi, Mariachiara, Paganelli, Valeria, Serafini, Marta, Riminucci, Mara, Locatelli, Franco, Quintarelli, Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636687/
https://www.ncbi.nlm.nih.gov/pubmed/36335396
http://dx.doi.org/10.1186/s13045-022-01376-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636687/
https://www.ncbi.nlm.nih.gov/pubmed/36335396
http://dx.doi.org/10.1186/s13045-022-01376-3

Ejemplares similares